Post Date | Body | Has new content | Topic | Forum | Name |
---|---|---|---|---|---|
In this video, Dr. McKean discusses combination immunotherapy vs. monotherapy for Metastatic Melanoma. Download Transcript HereMeredith McKean MD, MPH with Tennessee Oncology, Michael Postow, MD Chief of Melanoma service at Memorial Sloan Kettering and Sanjiv Agarwala, MD, Professor of Medical Oncology and Hematology at Temple University School of Medicine in Easton, PA joined GRACE to discuss current updates in treatment for Melanoma.
Check in regularly to our home page for new, up-to-date videos and articles then join us here on our forums to discuss or ask questions. If we, the moderators can't confidently comment on your post we ask our faculty to join the conversation. Check in regularly to our home page for new, up-to-date videos and articles then join us here on our forums to discuss or ask questions. If we, the moderators can't confidently comment on your post we ask our faculty to join the conversation.
Take care, Janine |
Metastatic Melanoma-Combination immunotherapy vs. monotherapy | General Discussion! | JanineT GRACE … | ||
In this video from the AM Question and Answer Session of the event, Drs. West, Raez, Weiss and Janne discuss the role of liquid biopsies to track disease response and the potential for acquired resistance.
Denise is breaking down the plethora of information from the 2020 Targeted Therapies Forum. Thanks DBrock! For a full break down of the 2020 Targeted Therapies Forum, search, "2020 ttf"
Don't miss the transcription links at the top of the page, just under the subtitle.
Stay safe, Janine |
2020 TTF AM SESSION Q&A Panel - The Role of Liquid Biopsies | General Lung/Thoracic Cancer | JanineT GRACE … | ||
Here's another end of year review of new data. Watch out, it's hopeful!
"Debio/ Xevinapant Study Update What Have We Learned About Debio 1143 (Xevinapant) in Combination with Chemoradiation Therapy for Patients With HNSCC?" |
ASCO/ESMO 2020 Debio 1143/ Xevinapant Study Update | Metastatic Recurrent | JanineT GRACE … | ||
Here's a new head and neck cancer video. Not only can't I say enough about how much I appreciate learning about new findings but they speak about the fact that they have different approaches to the same case description. Just knowing that lets me know I need to discuss my goals and options for treatment when there isn't a clear direction. "For this discussion, Drs. Bauml, Weiss, Gold and Mehra discuss what we have learned from Keynote 048: First Line Regiments of Pembrolizumab Monotherapy vs. Pembrolizumab and Chemo for Patients with Recurrent or Metastatic HNSCC"I
I hope this helps someone or many someones Janine |
ASCO/ESMO 2020 - KEYNOTE 048 Study Update, What Have We Learned? | Metastatic Recurrent | JanineT GRACE … | ||
The research team at Tulane University is conducting an online survey of individuals with cancer.GRACE has been asked to share information about an anonymous one-time online research study about personality and cancer care. They are looking for adults with a history of cancer. A total number of 2,500 individuals will participate in the study, recruited from various social media platforms and websites dedicated to cancer research and patient support.
The survey takes about 30 minutes and involves personalized feedback about results on a personality test. Additional survey questions will ask about demographics, health history, mood. and feelings about cancer care. Tulane University hopes that the study will build knowledge that can help individuals with cancer to be more satisfied with their care. The Principle Investigator is Laura Perry, MS, Doctoral Candidate, and Faculty Mentor is Michael Hoerger, PhD, MSCR.
To take part of in and learn more about the study, please follow this link: https://tulane.co1.qualtrics.com/jfe/form/SV_2f1b8MH3hkzkvDT?fbclid=IwA…
**Please note that this research study is not a part of GRACE. This post is provided for informational purposes only. |
Tulane University online survey - looking for individuals with a cancer diagnosis | General Discussion! | dbrock | ||
Join the Global Resource for Advancing Cancer Education for 3 LiveOnline panel discussions covering updates on Immunotherapy and Combination Treatments, Small Cell Lung Cancer, and Early and Locally Advanced Non Small Cell Lung Cancer |
OncTalk 2020 Live Online Dec. 5 | General SCLC | JanineT GRACE … | ||
Join the Global Resource for Advancing Cancer Education for 3 LiveOnline panel discussions covering updates on Immunotherapy and Combination Treatments, Small Cell Lung Cancer, and Early and Locally Advanced Non Small Cell Lung Cancer |
OncTalk 2020 Live Online Dec. 5 | Locally Advanced NSCLC | JanineT GRACE … | ||
Join the Global Resource for Advancing Cancer Education for 3 LiveOnline panel discussions covering updates on Immunotherapy and Combination Treatments, Small Cell Lung Cancer, and Early and Locally Advanced Non Small Cell Lung Cancer |
OncTalk 2020 Live Online Dec. 5 | General Discussion! | JanineT GRACE … | ||
Hi CancerGrace Members,
Grace has been asked to pass along this invitation by Tulane University's Psycho-Oncology Research Program whose Mission Statement reads, "The mission of the Psycho-Oncology Research Program is to improve quality of life by anticipating, preventing, and alleviating the emotional and physical burden of cancer." Historically there has been much too little investigation into these matters and we are happy to see such research programs moving forward. Wishing all of you a safe week,
Janine
Our research team at Tulane University is conducting an online survey of individuals with cancer. (http://tulane.co1.qualtrics.
The study takes about 30 minutes and involves receiving personalized feedback about results on a personality test. Additional survey questions will ask about demographics, health history, mood, and feelings about cancer care. We hope that the study will build knowledge that can help individuals with cancer to be more satisfied with their care.
We would be happy to answer any questions you may have (Principal Investigator: Laura Perry, MS, Doctoral Candidate, lperry5@tulane.edu; Faculty Mentor: Michael Hoerger, PhD, MSCR, mhoerger@tulane.edu, (504) 314-7545). As well, we would be happy to send documents verifying ethical approval from the Tulane University Institutional Review Board (IRB) and a copy of the survey.
Thank you, Hallie Voss Hallie Voss | she/her Tulane University, New Orleans Accelerated Master’s Program | Health Psychology Psycho-Oncology Research Program hvoss@tulane.edu | 708-629-8130 |
Alleviating the Emotional and Physical Burden of Cancer-Online Research Survey | General Discussion! | JanineT GRACE … | ||
The Targeted Therapies Patient Forum from CancerGrace.org is finally here and FREE to anyone. Originally scheduled for earlier this year our forum is now going to be held live online this Saturday, September 12, 2020.
There’s no better way to get the most up to date information about research and real-life clinical practices than joining a group of professionals, patients, and caregivers for a day of lectures, panel discussions, and question and answer sessions.
You’ve heard the saying 2 heads are better than one? That goes doubly when you get a group of lung cancer specialists and researchers together. I’ve been a member of Grace for over 10 years and have learned so many invaluable lessons from these types of group discussions. This includes a variety of perspectives and detail only group discussions provide. You’ll have ample opportunity to ask questions. If you don’t already know, I think you’ll be heartened to see the genuine excitement from our faculty about new treatments and educating us so we can be players in the decision-making process.
If you or someone you care about has NSCLC with a targetable mutation you won’t want to miss this forum.
Here is the Agenda for Saturday, Faculty information, and Register here...See you there! |
9/12/2020 online Targeted Therapies Patient Forum | Stage IV NSCLC | JanineT GRACE … |